Table 2.
Participants with IBS (n = 146) | |||||
---|---|---|---|---|---|
Domain | Pre-LEAP intervention | Post-LEAP intervention | Mean Difference | 95% CI | P-Value |
Global GI symptom survey score | 15.8 ± 0.6 | 5.4 ± 0.4 | −10.4 | −9.1 ‒ −11.6 | <0.001 |
Heartburn/reflux | 1.4 ± 0.1 | 0.5 ± 0.1 | −0.9 | −0.7 ‒ −1.1 | <0.001 |
Stomach pains/cramps | 1.8 ± 0.1 | 0.7 ± 0.1 | −1.1 | −0.8 ‒ −1.3 | <0.001 |
Intestinal pains/cramps | 2.2 ± 0.1 | 0.7 ± 0.1 | −1.4 | −1.2 ‒ −1.7 | <0.001 |
Constipation | 1.6 ± 0.1 | 0.6 ± 0.1 | −1.0 | −0.7 ‒ −1.2 | <0.001 |
Diarrhea | 1.7 ± 0.1 | 0.5 ± 0.7 | −1.2 | −1.1 ‒ −1.5 | <0.001 |
Bloating sensation | 2.5 ± 0.1 | 0.8 ± 0.1 | −1.7 | −1.1 ‒ −1.9 | <0.001 |
Gas (of any kind) | 2.7 ± 0.1 | 1.2 ± 0.1 | −1.5 | −1.3 ‒ −1.7 | <0.001 |
Nausea/Vomiting | 0.9 ± 0.1 | 0.3 ± 0.1 | −0.6 | −0.6 ‒ −1.0 | <0.001 |
Painful elimination | 0.9 ± 0.1 | 0.1 ± 0.1 | −0.8 | −0.5 ‒ −0.8 | <0.001 |
Data is reported as Mean ± SE. P is considered significant at <0.05.